Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
FDA Rejects Request To Expand Nuplazid Use For Symptoms of Dementia-Related Psychosis April 6, 2021 Irvin Jackson Add Your Comments Federal health regulators have rejected an application filed by Acadia Pharmaceuticals to expand the use of its blockbuster antipsychotic drug, Nuplazid, highlighting concerns that the medication may not be effective among certain subgroups of dementia patients. In a Complete Response Letter (CRL) submitted by the U.S. Food and Drug Administration (FDA) on April 5, the agency denied the Acadia Pharmaceuticals application to extend approval of Nuplazid for treatment of hallucinations and delusions associated with other forms of dementia-related psychosis (DRP). Nuplazid (pimavanserin) is an atypical antipsychotic, which is currently indicated for reduction of hallucinations experienced by Parkinson’s disease patients. The drug was introduced by Acadia Pharmaceuticals in April 2016, after it was approved by the FDA through a fast track “Breakthrough Therapy” process. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Shortly after Nuplazid’s release, the medication brought in about $125 million sales in 2017, and Acadia Pharmaceuticals began a supplemental New Drug Application for Nuplazid seeking approval to market the drug for use among patients with various forms of dementia, including Alzheimer’s. Following a several year application, in which Acadia Pharmaceuticals submitted results of its required DRP pivotal HARMONY study for labeling and post-marketing requirements, the FDA rejected the label expansion Monday and took issue with the drug’s efficacy. According to the FDA’s response, the agency’s division of psychiatry found “the trial wasn’t enough to prove the drug’s effectiveness because of a lack of statistical significance in some patient subgroups—including those with Alzheimer’s disease—and the small numbers of patients with certain less common dementia subtypes.” The FDA further stated the included Phase 2 Alzheimer’s disease psychosis study was inadequate, lacking proper controls to account for certain protocol deviations in Alzheimer’s patients. The rejection came as a surprise to Acadia Pharmaceuticals, who reportedly stated the results of the FDA’s CRL were “very disappointing” and maintained the HARMONY study met its pre-specified endpoints to prove statistical superiority of pimavanserin over the placebo group. Acadia Pharmaceuticals was already facing concerns over the potential side effects of Nuplazid, after an alarming number of adverse events and patient deaths were reported, leading to serious questions about whether benefits outweigh the potential health risks and whether a Nuplazid recall may be necessary. In April 2018, the FDA launched a safety review into Nuplazid problems after receiving 2,236 adverse event reports over the course of its first year on the market, including 244 deaths and signs that the drug may actually worsen hallucinations in some cases. Since 2016, the FDA has received a total of 6,000 Nuplazid incident reports and 700 deaths, with at least 500 of the fatalities listing Nuplazid as the only suspect medication taken by the patient at the time. The Institute for Safe Medication Practices (ISMP) issued a warning about Nuplazid safety signals in its November 2017 QuarterWatch report, citing Nuplazid may cause a variety of undisclosed problems including falls, insomnia, nausea, and fatigue. As a result of the drug makers’ failure to adequately warn about the risks associated with their medication, Nuplazid injury lawyers are evaluating whether users may be entitled to compensation through a product liability lawsuit. Tags: Acadia, Alzheimer's Disease, Atypical Antipsychotic, Congress, Dementia, Drug Side Effects, Hallucinations, Nuplazid, Parkinsons Disease Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. More Lawsuit Stories Hundreds of Thousands of Uber Sexual Assaults Went Unreported for Years, NYT August 6, 2025 Deadlines in Teen Social Media Addiction Lawsuits Extended by MDL Judge August 6, 2025 $2.5 Billion New Jersey Water Contamination Settlement Reached With DuPont Over PFAS Dumping August 6, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hundreds of Thousands of Uber Sexual Assaults Went Unreported for Years, NYT (Posted: yesterday) An investigative report reveals Uber failed to report hundreds of thousands of sexual assault incidents between 2017 and 2022. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITUber Faces Lawsuit Over Passenger Injuries in Construction Zone Crash in Philadelphia (07/31/2025)Judge Rejects Uber’s Attempt To Dismiss All Driver Sex Assault Bellwether Lawsuits (07/15/2025)Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (07/10/2025) John Paul Mitchell Hair Dye Caused Bladder Cancer for Two Hair Dressers, Lawsuits Allege (Posted: 2 days ago) Two hair dye bladder cancer lawsuits have been brought against Paul Mitchell by cosmetologists who say they were exposed to chemicals in the products for decades. MORE ABOUT: HAIR DYE LAWSUITLawsuit Over Hair Dye Cancer Risks Filed on Behalf of California Citizens by Environmental Group (07/25/2025)Status of Hair Dye Bladder Cancer Lawsuits Outlined for Court (07/17/2025)12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (07/01/2025) Failed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (Posted: 3 days ago) BioZorb tissue marker lawsuit claims woman will need to undergo surgical removal of implant after it failed to properly dissolve. MORE ABOUT: BIOZORB LAWSUITProblems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025)Lawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (07/07/2025)
$2.5 Billion New Jersey Water Contamination Settlement Reached With DuPont Over PFAS Dumping August 6, 2025
Hundreds of Thousands of Uber Sexual Assaults Went Unreported for Years, NYT (Posted: yesterday) An investigative report reveals Uber failed to report hundreds of thousands of sexual assault incidents between 2017 and 2022. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITUber Faces Lawsuit Over Passenger Injuries in Construction Zone Crash in Philadelphia (07/31/2025)Judge Rejects Uber’s Attempt To Dismiss All Driver Sex Assault Bellwether Lawsuits (07/15/2025)Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (07/10/2025)
John Paul Mitchell Hair Dye Caused Bladder Cancer for Two Hair Dressers, Lawsuits Allege (Posted: 2 days ago) Two hair dye bladder cancer lawsuits have been brought against Paul Mitchell by cosmetologists who say they were exposed to chemicals in the products for decades. MORE ABOUT: HAIR DYE LAWSUITLawsuit Over Hair Dye Cancer Risks Filed on Behalf of California Citizens by Environmental Group (07/25/2025)Status of Hair Dye Bladder Cancer Lawsuits Outlined for Court (07/17/2025)12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (07/01/2025)
Failed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (Posted: 3 days ago) BioZorb tissue marker lawsuit claims woman will need to undergo surgical removal of implant after it failed to properly dissolve. MORE ABOUT: BIOZORB LAWSUITProblems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025)Lawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (07/07/2025)